&w=3840&q=100)
Banga family divests 2.1% stake in Nykaa's parent firm for ₹1,213 crore
Following the stake sale, shares of Nykaa declined by 4 per cent to ₹203.50 apiece on the BSE, and by 3.82 per cent to ₹203.50 per piece on the NSE.
Harindarpal Singh is a commodities billionaire and Chairman and CEO of Hong Kong-based Caravel Group. Banga was an early investor in Nykaa, which went public in 2021.
As per the deal, up to 6 crore equity shares of FSN were sold at a final price of ₹202.25 per share. This represents a discount of about 4.4 per cent to FSN's closing price of ₹211.59 on NSE on Wednesday, as per the term sheet accessed by PTI.
Goldman Sachs (India) Securities and J P Morgan India were the brokers for the deal.
The transaction comprises a sale of approximately 6 crore shares amounting to around 2.1 per cent stake in FSN.
At the final price, the total deal size is estimated at ₹1,213.5 crore ($141.9 million), which is executed in one or more bulk deals on the BSE and NSE. The offer is entirely secondary in nature.
After the latest transaction, Harindarpal's holding in Nykaa has come down to 2.87 per cent from 4.97 per cent.
Last month, FSN said it has set a break-even target of FY26 for its cash-burning fashion arm on account of marketing efficiencies, overhead leverage, and own-brand growth.
Nykaa is also making a foray into the quick-commerce arena with "Nykaa Now", which offers delivery time of 30 to 120 minutes across seven major cities. The service is backed by a network of beauty warehouses, physical retail stores and rapid stores across the country.
The fashion vertical, which generated about ₹3,800 crore in GMV (Gross Merchandise Value), is currently a drag on consolidated profitability, posting a Ebitda margin of (-) 8.3 per cent for FY25.
In May, Nykaa reported over threefold increase in consolidated net profit to ₹20.28 crore for the March quarter.
The fashion and beauty retailer had logged a profit (attributable to equity shareholders of the parent) of ₹6.93 crore in the year-ago period, according to a regulatory filing.
Revenue from operations was 23.6 per cent higher at ₹2,061.76 crore during the quarter, against ₹1,667.98 crore a year earlier.
However, seen sequentially, profit and revenue fell 22.3 per cent and 9 per cent, respectively.
In 2024-25, profit more than doubled to ₹66.08 crore, from ₹32.26 crore in the previous fiscal year. Revenue from operations stood at ₹7,949.82 crore, 24.4 per cent higher than ₹6,385.62 crore in FY24.
In FY25, Nykaa saw its cumulative customer base grow 28 per cent year-on-year to over 42 million.
In August last year, Harindarpal Singh Banga divested over 4 crore shares, or 1.43 per cent stake, in Nykaa for ₹851.50 crore.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
an hour ago
- The Hindu
CCI directs UltraTech/India Cements, Dalmia Bharat to furnish financial records
Fair trade regulator CCI has directed Aditya Birla firm UltraTech, which now owns South-based cement firm India Cements, along with two other cement makers and their executives to submit financial documents, after its Director General, in its investigations, found contravention of competition norms. The Competition Commission of India (CCI) has also directed Dalmia Bharat Cements and Shree Digvijay Cements to submit their audited financial statements, including balance sheets and profit and loss accounts, within eight weeks of the order. It has directed UltraTech to submit the financial statements of its subsidiary India Cements for five years from FY15 to FY19, while Dalmia Bharat Cements and Shree Digvijay Cements for nine years, from FY11 to FY19. Besides, CCI has also directed their executives to submit detailed financials and income tax records for five years, along with formal responses to the investigation report. An email sent to UltraTech Cements remained unanswered till the time of filing the story. Dalmia Bharat, in a regulatory filing, said CCI is yet to hear it in the matter or pass any formal order. "DCBL remains committed to full regulatory compliance and is cooperating with the authorities," it said. Allegation of cartelisation The CCI direction came over a complaint filed by ONGC alleging cartelisation in its tenders. Following this, the fair trade regulator had on November 18, 2020, directed its probe unit Director General to look into the issue. The DG had submitted its investigations report on February 18, 2025, in which found contraventions of the competition regulations. It had found that Ultratech's subsidiary India Cements, along with Shree Digvijay Cement and Dalmia Cement, with a middleman named Umakant Agarwal, engaged in anti-competitive collusion. Later, CCI on May 26, 2025, considered the investigation report and in a four-page order also directed the cement manufacturer to submit income derived from sales to alleged contraventions by the PSU. The CCI notice also mentioned if there is non-furnishing of the financial details or incomplete/false information, within the time frame by the companies, then they would be liable under section 45 of the Act. Earlier, in December 2024, UltraTech Cements had acquired 32.72% stake from promoters and promoter group entities of India Cements Ltd. The Aditya Birla Group firm, which already had acquired a 22.77% stake from the market, became the promoter of the Tamil Nadu-based company.
Mint
an hour ago
- Mint
Aster DM sets sights on pan-India expansion after merger with Quality Care
Aster DM Healthcare's merger with Blackstone-backed Quality Care India Ltd (QCIL) was an inflection point for the hospital chain as it embarks on an ambitious expansion plan, deputy managing director and promoter Alisha Moopen told Mint in an interview. The Bengaluru-based hospital group aims to expand its footprint across the country and become a pan-India healthcare leader in the next ten years, said Moopen. However, even as the company explores further inorganic opportunities, it is treading cautiously. 'It has to make business sense…transactions are hard to execute because Indian markets have become so hot," said Moopen. 'But if there's a great asset at the right price…of course, we'll look at it," she added. Read more: Apollo Hospitals: Simplifying corporate structure could lead to rerating The merged entity Aster DM Quality Care Ltd, jointly controlled by Aster's promoters and Blackstone, is in the fray for the acquisition of Canada's Ontario Teachers Pension Plan (OTPP)-owned Sahyadri Hospitals, according to media reports citing sources. The Pune-based hospital has also reportedly received bids from Manipal Hospitals, Sweden-based investment firm EQT, and Malaysia-based IHH Healthcare. While Moopen declined to comment on the Sahyadri bid, she said that Aster would focus on the brand, reputation, trust and valuation of an asset when evaluating an acquisition. '…for us, we are all about sustainable growth," she said. Aster DM announced in late November 2024 that it was merging with QCIL in a deal that will value the combined entity at $5.08 billion ( ₹43,000 crore). The merger is expected to conclude in the next six months. The deal catapulted the merged entity among the top three hospital chains in India by bed size. The combined entity will have 10,301 beds, doubling from Aster DM's current bed capacity of 5,159. It also opens up new markets for Aster, which already has a strong footprint in Kerala and Karnataka, in new states like Madhya Pradesh, Odisha, Chhattisgarh and Tamil Nadu. 'The transaction is an inflection point for the organization, and it's something which we believe will really set us up to become the gold standard for healthcare here," said Moopen, adding that the hospital chain, which has its roots in Dubai, is 'probably one of the youngest [healthcare] brands in this country". 'We were spending a lot of time just setting up the core and setting the foundation. But now hopefully with this merger, we can really sort of have that exponential growth," said Moopen. Expansion plans The merged entity has plans to grow organically through greenfield and brownfield projects in south and central India where Aster DM and Quality Care have strongholds. The total planned bed addition is over 3,300 beds over the next three years. However, growing pan-India and entering new markets is more challenging, said Moopen. 'It takes a good five to ten years to understand a new market," she said, adding that it's all about understanding regional nuances. However, making inroads through an already established player, via an acquisition or a merger, offers up an opportunity to meaningfully scale up in new markets, she added. 'When the merger was happening, that was one of the biggest advantages we saw. Because it opens up three, four new states for us," said Moopen. '...we said, this is great. We don't have to go in from scratch." Read more: Inside Cipla's battle with 'superbugs' as antibiotic resistance rises in India The company plans to grow organically for the next three to four years in its core markets through strategic bed capacity addition, with a total capex outlay of ₹1,878 crore. However, the company is already eyeing the North India market and hopes to start making inroads in the next two to three years. 'Whether we plan that organically or inorganically will depend on what happens in the next couple of years in terms of the opportunities that come up…we are evaluating all aspects," said Moopen. The company plans to fund its organic growth through internal accruals, and will explore raising debt for its inorganic plans, said Moopen. India's private healthcare space is seeing a spree of expansions and consolidation, with major competitors like Apollo Hospitals, Max Healthcare and Narayana Health announcing large expansion plans for the next four to five years. According to a 2024 report by HSBC Global Research, seven listed hospitals will add 14,000 beds over the course of 3-5 years. Read more: Will Torrent Pharma's big bet on JB Chemicals pay off?
Economic Times
an hour ago
- Economic Times
Second-hand car prices in Delhi drop due to restrictions on end-of-life vehicles, says trade body
Second-hand car prices in Delhi have plummeted by 40-50% due to restrictions on older vehicles, according to the Chamber of Trade and Industry. Chairman Brijesh Goyal noted that nearly 60 lakh vehicles are affected, forcing traders to sell at significantly reduced prices. Demand from other states like Punjab and Uttar Pradesh is accompanied by aggressive bargaining, further impacting profits. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Prices of second-hand cars in the national capital have witnessed a sharp fall in recent days, with traders reporting a decline of 40 to 50 per cent, the Chamber of Trade and Industry (CTI) said on Chairman Brijesh Goyal said the market for overage vehicles in Delhi has been severely affected, with nearly 60 lakh vehicles impacted by the sudden attributed the price crash to restrictions related to End-of-Life (EOL) vehicles, which have crossed the permissible age limit for operation in who is also an automobile businessman, claimed that traders are being forced to sell cars at significantly lower prices."In the last five days, the prices of second-hand cars have dropped by 40 to 50 per cent. Businessmen in Delhi are now compelled to sell vehicles at one-fourth of their original price," he said that second-hand cars from Delhi are usually sold in Punjab, Rajasthan, Uttar Pradesh, Bihar, Tamil Nadu, Karnataka and Kerala. However, the demand from outside states is now accompanied by aggressive bargaining."Luxury used cars that earlier fetched Rs six to seven lakh are now being sold for barely Rs four to five lakh. Buyers from other states are aware of the challenges faced by Delhi-based traders and are negotiating accordingly," Goyal further added that over 1,000 traders in areas like Karol Bagh, Preet Vihar, Pitampura, and Moti Nagar are involved in the business of selling second-hand dealers have also raised concerns over difficulties in obtaining the No Objection Certificate (NOC) from the Transport Department, which is required to sell used vehicles in other the process was relatively smooth, but now traders say they are facing delays and Delhi government had banned fuel for end-of-life vehicles -- 10 years or older for diesel vehicles and 15 years or older for petrol vehicles -- that are deregistered and not allowed to ply on the roads from July 1, following a court on Thursday, the government requested the Commission for Air Quality Management (CAQM) to put the ban on hold with immediate effect, arguing that the fuel ban on overage vehicles is not feasible due to technological challenges.
